Related Experiment Video

Updated: Aug 18, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

[Levels of B-endorphin in patients with silent myocardial ischemia]

P Salomon1, W Mazurek

  • 1Katedry i Kliniki Kardiologii Akademii Medycznej we Wrocławiu.

Polskie Archiwum Medycyny Wewnetrznej
|June 1, 1994
PubMed

Insights

Patients with silent myocardial ischemia have higher plasma beta-endorphin levels. This suggests beta-endorphin may play a role in the development of painless heart ischemia.

Area of Science:

  • Cardiology
  • Endocrinology
  • Biochemistry

Context:

  • Assessing plasma beta-endorphin in coronary artery disease patients.
  • Investigating silent myocardial ischemia versus painful ischemia.
  • Utilizing radioimmunoassay for beta-endorphin quantification.

Purpose:

  • To determine plasma beta-endorphin levels in patients with painless myocardial ischemia.
  • To compare beta-endorphin levels between silent and painful myocardial ischemia.
  • To explore the potential role of beta-endorphin in the etiopathogenesis of silent myocardial ischemia.

Summary:

  • Plasma beta-endorphin levels were measured in 90 coronary artery disease patients (55 post-myocardial infarction, 35 chronic stable angina) and 22 healthy controls.
  • Measurements were taken at rest, immediately post-exercise, and 6 minutes post-exercise using a radioimmunologic method.
  • Results indicated significantly higher plasma beta-endorphin levels in patients with silent myocardial ischemia compared to those with painful ischemia, both at rest and during exercise.

Impact:

  • Elevated plasma beta-endorphin may be an etiopathogenetic factor in silent myocardial ischemia.
  • Findings contribute to understanding the neuroendocrine basis of ischemic heart disease.
  • Highlights potential differences in endogenous opioid system activity between symptomatic and asymptomatic ischemia.

More Related Videos

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...